Chapter/Section Purchase

Table of Contents
1 Market Overview
1.1 Drugs for Malaria Introduction
1.2 Market Analysis by Type
1.2.1 Aryl Aminoalcohol Compounds
1.2.2 Antifolate Compounds
1.2.3 Artemisinin Compounds
1.3 Market Analysis by Applications
1.3.1 Prevention
1.3.2 Treatment
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2017-2028)
1.4.1.2 Canada Market States and Outlook (2017-2028)
1.4.1.3 Mexico Market States and Outlook (2017-2028)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2017-2028)
1.4.2.2 France Market States and Outlook (2017-2028)
1.4.2.3 UK Market States and Outlook (2017-2028)
1.4.2.4 Russia Market States and Outlook (2017-2028)
1.4.2.5 Italy Market States and Outlook (2017-2028)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2017-2028)
1.4.3.2 Japan Market States and Outlook (2017-2028)
1.4.3.3 Korea Market States and Outlook (2017-2028)
1.4.3.4 India Market States and Outlook (2017-2028)
1.4.3.5 Southeast Asia Market States and Outlook (2017-2028)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2017-2028)
1.4.4.2 Egypt Market States and Outlook (2017-2028)
1.4.4.3 Saudi Arabia Market States and Outlook (2017-2028)
1.4.4.4 South Africa Market States and Outlook (2017-2028)
1.4.4.5 Nigeria Market States and Outlook (2017-2028)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cipla
2.1.1 Business Overview
2.1.2 Drugs for Malaria Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.2 Guilin Pharmaceutical
2.2.1 Business Overview
2.2.2 Drugs for Malaria Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.3 IPCA Laboratories
2.3.1 Business Overview
2.3.2 Drugs for Malaria Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Drugs for Malaria Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.5 Mylan Labs
2.5.1 Business Overview
2.5.2 Drugs for Malaria Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.6 Roche
2.6.1 Business Overview
2.6.2 Drugs for Malaria Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Drugs for Malaria Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.8 Sanofi Aventis
2.8.1 Business Overview
2.8.2 Drugs for Malaria Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.9 Ajanta Pharma
2.9.1 Business Overview
2.9.2 Drugs for Malaria Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
3 Global Drugs for Malaria Market Competition, by Manufacturer
3.1 Global Drugs for Malaria Sales and Market Share by Manufacturer (2020-2021)
3.2 Global Drugs for Malaria Revenue and Market Share by Manufacturer (2020-2021)
3.3 Global Drugs for Malaria Price by Manufacturer (2020-2021)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Malaria Manufacturer Market Share in 2021
3.4.2 Top 5 Drugs for Malaria Manufacturer Market Share in 2021
3.5 Market Competition Trend
4 Global Drugs for Malaria Market Analysis by Regions
4.1 Global Drugs for Malaria Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Malaria Sales by Regions (2017-2022)
4.1.2 Global Drugs for Malaria Revenue by Regions (2017-2022)
4.2 North America Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)
4.3 Europe Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)
4.4 Asia-Pacific Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)
4.5 South America Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)
4.6 Middle East and Africa Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)
5 North America Drugs for Malaria by Countries, Type, Application and Manufacturers
5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Malaria Sales by Countries (2017-2022)
5.1.2 North America Drugs for Malaria Revenue by Countries (2017-2022)
5.1.3 United States Drugs for Malaria Sales and Growth Rate (2017-2022)
5.1.4 Canada Drugs for Malaria Sales and Growth Rate (2017-2022)
5.1.5 Mexico Drugs for Malaria Sales and Growth Rate (2017-2022)
5.2 North America Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2020-2021)
5.2.1 North America Drugs for Malaria Sales by Manufacturers (2020-2021)
5.2.2 North America Drugs for Malaria Revenue by Manufacturers (2020-2021)
5.3 North America Drugs for Malaria Sales, Revenue and Market Share by Type (2017-2022)
5.3.1 North America Drugs for Malaria Sales and Sales Share by Type (2017-2022)
5.3.2 North America Drugs for Malaria Revenue and Revenue Share by Type (2017-2022)
5.4 North America Drugs for Malaria Sales, Revenue and Market Share by Application (2017-2022)
5.4.1 North America Drugs for Malaria Sales and Sales Share by Application (2017-2022)
5.4.2 North America Drugs for Malaria Revenue and Revenue Share by Application (2017-2022)
6 Europe Drugs for Malaria by Countries, Type, Application and Manufacturers
6.1 Europe Drugs for Malaria Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Malaria Sales by Countries (2017-2022)
6.1.2 Europe Drugs for Malaria Revenue by Countries (2017-2022)
6.1.3 Germany Drugs for Malaria Sales and Growth Rate (2017-2022)
6.1.4 UK Drugs for Malaria Sales and Growth Rate (2017-2022)
6.1.5 France Drugs for Malaria Sales and Growth Rate (2017-2022)
6.1.6 Russia Drugs for Malaria Sales and Growth Rate (2017-2022)
6.1.7 Italy Drugs for Malaria Sales and Growth Rate (2017-2022)
6.2 Europe Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2020-2021)
6.2.1 Europe Drugs for Malaria Sales by Manufacturers (2020-2021)
6.2.2 Europe Drugs for Malaria Revenue by Manufacturers (2020-2021)
6.3 Europe Drugs for Malaria Sales, Revenue and Market Share by Type (2017-2022)
6.3.1 Europe Drugs for Malaria Sales and Sales Share by Type (2017-2022)
6.3.2 Europe Drugs for Malaria Revenue and Revenue Share by Type (2017-2022)
6.4 Europe Drugs for Malaria Sales, Revenue and Market Share by Application (2017-2022)
6.4.1 Europe Drugs for Malaria Sales and Sales Share by Application (2017-2022)
6.4.2 Europe Drugs for Malaria Revenue and Revenue Share by Application (2017-2022)
7 Asia-Pacific Drugs for Malaria by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Malaria Sales by Countries (2017-2022)
7.1.2 Asia-Pacific Drugs for Malaria Revenue by Countries (2017-2022)
7.1.3 China Drugs for Malaria Sales and Growth Rate (2017-2022)
7.1.4 Japan Drugs for Malaria Sales and Growth Rate (2017-2022)
7.1.5 Korea Drugs for Malaria Sales and Growth Rate (2017-2022)
7.1.6 India Drugs for Malaria Sales and Growth Rate (2017-2022)
7.1.7 Southeast Asia Drugs for Malaria Sales and Growth Rate (2017-2022)
7.2 Asia-Pacific Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2020-2021)
7.2.1 Asia-Pacific Drugs for Malaria Sales by Manufacturers (2020-2021)
7.2.2 Asia-Pacific Drugs for Malaria Revenue by Manufacturers (2020-2021)
7.3 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Type (2017-2022)
7.3.1 Asia-Pacific Drugs for Malaria Sales and Sales Share by Type (2017-2022)
7.3.2 Asia-Pacific Drugs for Malaria Revenue and Revenue Share by Type (2017-2022)
7.4 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Application (2017-2022)
7.4.1 Asia-Pacific Drugs for Malaria Sales and Sales Share by Application (2017-2022)
7.4.2 Asia-Pacific Drugs for Malaria Revenue and Revenue Share by Application (2017-2022)
8 South America Drugs for Malaria by Countries, Type, Application and Manufacturers
8.1 South America Drugs for Malaria Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Malaria Sales by Countries (2017-2022)
8.1.2 South America Drugs for Malaria Revenue by Countries (2017-2022)
8.1.3 Brazil Drugs for Malaria Sales and Growth Rate (2017-2022)
8.1.4 Argentina Drugs for Malaria Sales and Growth Rate (2017-2022)
8.1.5 Colombia Drugs for Malaria Sales and Growth Rate (2017-2022)
8.2 South America Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2020-2021)
8.2.1 South America Drugs for Malaria Sales by Manufacturers (2020-2021)
8.2.2 South America Drugs for Malaria Revenue by Manufacturers (2020-2021)
8.3 South America Drugs for Malaria Sales, Revenue and Market Share by Type (2017-2022)
8.3.1 South America Drugs for Malaria Sales and Sales Share by Type (2017-2022)
8.3.2 South America Drugs for Malaria Revenue and Revenue Share by Type (2017-2022)
8.4 South America Drugs for Malaria Sales, Revenue and Market Share by Application (2017-2022)
8.4.1 South America Drugs for Malaria Sales and Sales Share by Application (2017-2022)
8.4.2 South America Drugs for Malaria Revenue and Revenue Share by Application (2017-2022)
9 Middle East and Africa Drugs for Malaria by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Malaria Sales by Countries (2017-2022)
9.1.2 Middle East and Africa Drugs for Malaria Revenue by Countries (2017-2022)
9.1.3 Saudi Arabia Drugs for Malaria Sales and Growth Rate (2017-2022)
9.1.4 UAE Drugs for Malaria Sales and Growth Rate (2017-2022)
9.1.5 Egypt Drugs for Malaria Sales and Growth Rate (2017-2022)
9.1.6 Nigeria Drugs for Malaria Sales and Growth Rate (2017-2022)
9.1.7 South Africa Drugs for Malaria Sales and Growth Rate (2017-2022)
9.2 Middle East and Africa Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2020-2021)
9.2.1 Middle East and Africa Drugs for Malaria Sales by Manufacturers (2020-2021)
9.2.2 Middle East and Africa Drugs for Malaria Revenue by Manufacturers (2020-2021)
9.3 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Type (2017-2022)
9.3.1 Middle East and Africa Drugs for Malaria Sales and Sales Share by Type (2017-2022)
9.3.1 Middle East and Africa Drugs for Malaria Revenue and Revenue Share by Type (2017-2022)
9.4 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Application (2017-2022)
9.4.1 Middle East and Africa Drugs for Malaria Sales and Sales Share by Application (2017-2022)
9.4.2 Middle East and Africa Drugs for Malaria Revenue and Revenue Share by Application (2017-2022)
10 Global Drugs for Malaria Market Segment by Type
10.1 Global Drugs for Malaria Sales, Revenue and Market Share by Type (2017-2022)
10.1.1 Global Drugs for Malaria Sales and Market Share by Type (2017-2022)
10.1.2 Global Drugs for Malaria Revenue and Market Share by Type (2017-2022)
10.2 Aryl Aminoalcohol Compounds Sales Growth and Price
10.2.1 Global Aryl Aminoalcohol Compounds Sales Growth (2017-2022)
10.2.2 Global Aryl Aminoalcohol Compounds Price (2017-2022)
10.3 Antifolate Compounds Sales Growth and Price
10.3.1 Global Antifolate Compounds Sales Growth (2017-2022)
10.3.2 Global Antifolate Compounds Price (2017-2022)
10.4 Artemisinin Compounds Sales Growth and Price
10.4.1 Global Artemisinin Compounds Sales Growth (2017-2022)
10.4.2 Global Artemisinin Compounds Price (2017-2022)
11 Global Drugs for Malaria Market Segment by Application
11.1 Global Drugs for Malaria Sales Market Share by Application (2017-2022)
11.2 Prevention Sales Growth (2017-2022)
11.3 Treatment Sales Growth (2017-2022)
11.4 Other Sales Growth (2017-2022)
12 Drugs for Malaria Market Forecast (2022-2028)
12.1 Global Drugs for Malaria Sales, Revenue and Growth Rate (2022-2028)
12.2 Drugs for Malaria Market Forecast by Regions (2022-2028)
12.2.1 North America Drugs for Malaria Market Forecast (2022-2028)
12.2.2 Europe Drugs for Malaria Market Forecast (2022-2028)
12.2.3 Asia-Pacific Drugs for Malaria Market Forecast (2022-2028)
12.2.4 South America Drugs for Malaria Market Forecast (2022-2028)
12.2.5 Middle East and Africa Drugs for Malaria Market Forecast (2022-2028)
12.3 Drugs for Malaria Market Forecast by Type (2022-2028)
12.3.1 Global Drugs for Malaria Sales Forecast by Type (2022-2028)
12.3.2 Global Drugs for Malaria Market Share Forecast by Type (2022-2028)
12.4 Drugs for Malaria Market Forecast by Application (2022-2028)
12.4.1 Global Drugs for Malaria Sales Forecast by Application (2022-2028)
12.4.2 Global Drugs for Malaria Market Share Forecast by Application (2022-2028)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source